Biocon Ltd. is a prominent biopharmaceutical company based in India, specializing in the development and production of innovative and cost-effective medical therapies. The company's primary focus lies... Biocon Ltd. is a prominent biopharmaceutical company based in India, specializing in the development and production of innovative and cost-effective medical therapies. The company's primary focus lies in biopharmaceuticals, including biologics, biosimilars, complex active pharmaceutical ingredients (APIs), and branded formulations. Serving various sectors, Biocon operates in oncology, diabetes, and autoimmune diseases, where it delivers health solutions through its research-driven approach and state-of-the-art manufacturing facilities. As an integral player in the global pharmaceuticals market, Biocon emphasizes leveraging its robust R&D capabilities to drive product innovation and affordability across multiple healthcare systems worldwide. The company's strategic collaborations and partnerships reinforce its role in advancing accessible healthcare, contributing significantly to the biopharmaceutical industry's growth and evolution. Founded in 1978, Biocon Ltd. has expanded its footprint beyond the Indian market, establishing a significant international presence and playing a crucial role in enhancing global healthcare outcomes.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Biocon

We reviewed Biocon's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Biocon's data?

Start your 30-day free trial to request a data review for Biocon.

Start Free Trial

Legal Center Contact Us